Cardlytics
CDLX
112 hedge funds and large institutions have $463M invested in Cardlytics in 2023 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 36 increasing their positions, 33 reducing their positions, and 18 closing their positions.
167% more capital invested
Capital invested by funds: $173M → $463M (+$290M)
19% more call options, than puts
Call options by funds: $16.6M | Put options by funds: $13.9M
14% more funds holding in top 10
Funds holding in top 10: 7 → 8 (+1)
11% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 18
2% more funds holding
Funds holding: 110 → 112 (+2)
9% more repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 33
0.65% less ownership
Funds ownership: 8.08% → 7.43% (-0.65%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
+$8.8M |
| 2 |
N
Nuveen
Charlotte,
North Carolina
|
+$5.98M |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
+$5.63M |
| 4 |
Morgan Stanley
New York
|
+$4.69M |
| 5 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
+$4.14M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
-$5.08M |
| 2 |
D.E. Shaw & Co
New York
|
-$4.34M |
| 3 |
6CM
683 Capital Management
New York
|
-$3.77M |
| 4 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
-$3.44M |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$2.79M |
CDLX Hedge Fund Activity: Q3 2023 in Review
112 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Cardlytics (CDLX) for Q3 2023, worth a combined $463M — up 167% from $173M a quarter earlier.
Buyers outnumbered sellers: 20 funds opened new CDLX positions and 18 closed out — a net gain of 2 holders — while 36 added to existing stakes and 33 trimmed.
The largest buyer was Invesco, adding an estimated $8.8M. The largest seller was Baillie Gifford & Co, cutting an estimated $5.08M.
- 112 institutional investors held Cardlytics (CDLX) as of Q3 2023, up from 110 in Q2 2023.
- Funds reported $463M of Cardlytics stock for Q3 2023, up 167% quarter-over-quarter.
- 20 funds opened new Cardlytics positions in Q3 2023 and 18 closed out, a net change of +2 holders.
- The largest Cardlytics buyer in Q3 2023 was Invesco, an estimated $8.8M added.
- The largest Cardlytics seller in Q3 2023 was Baillie Gifford & Co, an estimated $5.08M sold.
Based on aggregated 13F filings for Q3 2023.